Suppliers and packages for generic ingredient: BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
✉ Email this page to a colleague
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251 | NDA | A-S Medication Solutions | 50090-6247-0 | 30 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0) | 2018-02-07 |
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251 | NDA | Gilead Sciences, Inc. | 61958-2501-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-2501-1) | 2018-02-07 |
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251 | NDA | Gilead Sciences, Inc. | 61958-2501-2 | 7 TABLET in 1 BOTTLE, PLASTIC (61958-2501-2) | 2018-02-07 |
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251 | NDA | Gilead Sciences, Inc. | 61958-2501-3 | 30 TABLET in 1 BLISTER PACK (61958-2501-3) | 2018-02-07 |
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251 | NDA | Gilead Sciences, Inc. | 61958-2505-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-2505-1) | 2021-10-07 |
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251 | NDA | Gilead Sciences, Inc. | 61958-2506-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-2506-1) | 2024-10-08 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
